Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

History of myeloid-derived suppressor cells.

Talmadge JE, Gabrilovich DI.

Nat Rev Cancer. 2013 Oct;13(10):739-52. doi: 10.1038/nrc3581. Review.

2.

Contribution of myeloid-derived suppressor cells to tumor-induced immune suppression, angiogenesis, invasion and metastasis.

Ye XZ, Yu SC, Bian XW.

J Genet Genomics. 2010 Jul;37(7):423-30. doi: 10.1016/S1673-8527(09)60061-8.

PMID:
20659706
3.

HMGB1 enhances immune suppression by facilitating the differentiation and suppressive activity of myeloid-derived suppressor cells.

Parker KH, Sinha P, Horn LA, Clements VK, Yang H, Li J, Tracey KJ, Ostrand-Rosenberg S.

Cancer Res. 2014 Oct 15;74(20):5723-33. doi: 10.1158/0008-5472.CAN-13-2347. Epub 2014 Aug 27.

4.

Myeloid-derived suppressor cells in cancer: therapeutic, predictive, and prognostic implications.

Diaz-Montero CM, Finke J, Montero AJ.

Semin Oncol. 2014 Apr;41(2):174-84. doi: 10.1053/j.seminoncol.2014.02.003. Epub 2014 Feb 14. Review.

5.
6.

Expansion and functions of myeloid-derived suppressor cells in the tumor microenvironment.

Qu P, Wang LZ, Lin PC.

Cancer Lett. 2016 Sep 28;380(1):253-6. doi: 10.1016/j.canlet.2015.10.022. Epub 2015 Oct 28. Review.

PMID:
26519756
7.

Immunosuppressive cells and tumour microenvironment: focus on mesenchymal stem cells and myeloid derived suppressor cells.

Bianchi G, Borgonovo G, Pistoia V, Raffaghello L.

Histol Histopathol. 2011 Jul;26(7):941-51. doi: 10.14670/HH-26.941. Review.

PMID:
21630223
8.

EphA4-deleted microenvironment regulates cancer development and leukemoid reaction of the isografted 4T1 murine breast cancer via reduction of an IGF1 signal.

Jing X, Sonoki T, Miyajima M, Sawada T, Terada N, Takemura S, Sakaguchi K.

Cancer Med. 2016 Jun;5(6):1214-27. doi: 10.1002/cam4.670. Epub 2016 Feb 29.

9.

Myeloid-derived suppressor cell heterogeneity and subset definition.

Peranzoni E, Zilio S, Marigo I, Dolcetti L, Zanovello P, Mandruzzato S, Bronte V.

Curr Opin Immunol. 2010 Apr;22(2):238-44. doi: 10.1016/j.coi.2010.01.021. Epub 2010 Feb 17. Review.

PMID:
20171075
10.

MDSC as a mechanism of tumor escape from sunitinib mediated anti-angiogenic therapy.

Finke J, Ko J, Rini B, Rayman P, Ireland J, Cohen P.

Int Immunopharmacol. 2011 Jul;11(7):856-61. doi: 10.1016/j.intimp.2011.01.030. Epub 2011 Feb 11.

11.

Cancer-associated myeloproliferation: old association, new therapeutic target.

Wilcox RA.

Mayo Clin Proc. 2010 Jul;85(7):656-63. doi: 10.4065/mcp.2010.0077. Review.

12.

Tolerance and immune suppression in the tumor microenvironment.

Ostrand-Rosenberg S.

Cell Immunol. 2016 Jan;299:23-9. doi: 10.1016/j.cellimm.2015.09.011. Epub 2015 Sep 30.

13.

Mechanisms of intimate and long-distance cross-talk between glioma and myeloid cells: how to break a vicious cycle.

Wurdinger T, Deumelandt K, van der Vliet HJ, Wesseling P, de Gruijl TD.

Biochim Biophys Acta. 2014 Dec;1846(2):560-75. doi: 10.1016/j.bbcan.2014.10.003. Epub 2014 Oct 20. Review.

PMID:
25453365
14.

Regulation of tumor metastasis by myeloid-derived suppressor cells.

Condamine T, Ramachandran I, Youn JI, Gabrilovich DI.

Annu Rev Med. 2015;66:97-110. doi: 10.1146/annurev-med-051013-052304. Epub 2014 Oct 9. Review.

15.

Myeloid-derived suppressor cells in cancer: recent progress and prospects.

Khaled YS, Ammori BJ, Elkord E.

Immunol Cell Biol. 2013 Sep;91(8):493-502. doi: 10.1038/icb.2013.29. Epub 2013 Jun 25. Review.

PMID:
23797066
16.

Tumor- and organ-dependent infiltration by myeloid-derived suppressor cells.

Younos I, Donkor M, Hoke T, Dafferner A, Samson H, Westphal S, Talmadge J.

Int Immunopharmacol. 2011 Jul;11(7):816-26. doi: 10.1016/j.intimp.2011.02.021. Epub 2011 Mar 2.

PMID:
21376153
17.

Myeloid-derived suppressor cells in the tumor microenvironment: expect the unexpected.

Marvel D, Gabrilovich DI.

J Clin Invest. 2015 Sep;125(9):3356-64. doi: 10.1172/JCI80005. Epub 2015 Jul 13. Review.

18.

In Brief: Myeloid-derived suppressor cells in cancer.

Solito S, Pinton L, Mandruzzato S.

J Pathol. 2017 May;242(1):7-9. doi: 10.1002/path.4876. Epub 2017 Mar 21.

19.

Myeloid-derived suppressor cell development is regulated by a STAT/IRF-8 axis.

Waight JD, Netherby C, Hensen ML, Miller A, Hu Q, Liu S, Bogner PN, Farren MR, Lee KP, Liu K, Abrams SI.

J Clin Invest. 2013 Oct;123(10):4464-78. doi: 10.1172/JCI68189. Epub 2013 Sep 16.

20.

IFN regulatory factor 8 represses GM-CSF expression in T cells to affect myeloid cell lineage differentiation.

Paschall AV, Zhang R, Qi CF, Bardhan K, Peng L, Lu G, Yang J, Merad M, McGaha T, Zhou G, Mellor A, Abrams SI, Morse HC 3rd, Ozato K, Xiong H, Liu K.

J Immunol. 2015 Mar 1;194(5):2369-79. doi: 10.4049/jimmunol.1402412. Epub 2015 Feb 2.

Supplemental Content

Support Center